Northwestern University Lead Academic Participating Site, GY4 Supplemental Request

西北大学主导学术参与网站，GY4 补充请求

• 批准号: 10736415
• 负责人: AL B BENSON
• 金额: $ 30万
• 依托单位: NORTHWESTERN UNIVERSITY AT CHICAGO
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-11-11 至 2023-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10736415
• 关键词: Advanced Malignant Neoplasm; American College of Radiology Imaging Network; Ancillary Study; Area; Cancer Intervention; Chicago; Clinical Research; Clinical Trials; Collaborations; Comprehensive Cancer Center; Eastern Cooperative Oncology Group; Faculty; Goals; Home; Infrastructure; Institution; International; Lead; Leadership; Malignant Neoplasms; Patient Recruitments; Patients; Persons; Productivity; Recording of previous events; Research Infrastructure; Resources; Role; Science; Scientific Advances and Accomplishments; Site; Southwest Oncology Group; Universities; improved; inter-institutional; metropolitan; recruit; senior faculty

Summary/Abstract: The Robert H. Lurie Comprehensive Cancer Center of Northwestern University (LCC) has a long history of NCTN participation with ECOG membership since 1973. Currently, the LCC infrastructure supports participation in clinical trials and ancillary studies through the ECOG-ACRIN, SWOG, Alliance, NRG, and COG. LCC has an established history of accruing to and participating in NCTN trials including selection as a high performing site in 2015, 2016 and 2017. In 2019, Northwestern University was designated as a Lead Academic Performing site (LAPS) and in this new role continues to significantly accrue patients to NCTN trials, exceeding planned accrual goals in both years as a LAPS institution. Through continued demonstration of significant scientific accomplishments and new initiatives, recruitment of accomplished senior faculty and productive junior faculty, comprehensive and integrated infrastructure for oversight of cancer-related clinical trials, LCC will continue to expand participation in NCTN trials, provide scientific leadership of key network activities, and increase inter-institutional collaborations and access to unique scientific resources, to advance cancer interventions.

总结/摘要： 罗伯特·H。西北大学Lurie综合癌症中心（LCC）有着悠久的NCTN历史 自1973年以来一直是联合国西非经济共同体成员。目前，LCC基础设施支持参与 通过ECOG-ACRIN、SWOG、Alliance、NRG和COG进行的临床试验和辅助研究。LCC有一个 建立了参与NCTN试验的历史，包括选择高性能研究中心， 2015年、2016年和2017年。 在2019年，西北大学被指定为领先的学术表演网站（LAPS），并在这个新的 NCTN试验的患者继续显著增加，超过了两年的计划增加目标， LAPS机构。 通过不断展示重大科学成就和新举措， 完成高级教师和生产初级教师，全面和综合的基础设施， 为了监督癌症相关临床试验，LCC将继续扩大参与NCTN试验， 关键网络活动的科学领导，并增加机构间合作和获得独特的 科学资源，以推进癌症干预。